Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorThe University of Texas Health Science Center, Houston

About this trial

The purpose of this study is to see how well the ActiveMatrix® graft works at improving healing and function of the shoulder following rotator cuff repair surgery

Eligibility criteria

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability for the duration of the study

1-2 tendon full thickness reparable rotator cuff tendon tear(s)

Failed conservative medical management of the rotator cuff tendon tear defined as: 4-6 weeks of formal physical therapy or guided home exercises and activity modification

Disqualifiers

Prior surgery on the index shoulder within 12 months of enrollment, including Latarjet procedures, superior labral treat from anterior to posterior (SLAP), and (failed) primary rotator cuff surgery,

Prior surgery for bone defects requiring bone implantation in the index shoulder,

Steroid injection into the index shoulder within 6 weeks of enrollment.

Subscapularis tear greater than 1/3 of tendon involvement requiring repair,

Trial design

Treatments tested in this trial

  • ActiveMatrix® Dosage A
  • ActiveMatrix® Dosage B
  • Saline injection

Treatment groups

72 Participants
are divided into 3 treatment groups

Sponsors and collaborators